Located in Idaho Falls, Idaho, Rocky Mountain Clinical Research is highly esteemed by producers of medications, insulin pumps and other modalities related to diabetes. We are highly sought after for our clinical research expertise.
We are an integral member of a family of medical companies including Rocky Mountain Diabetes Center , Express Lab, and Rocky Mountain Pharmacy. As part of Rocky Mountain Diabetes Center, clinical research has been a big part of our practice for more than 20 years. We have collaborated with most of the major pharmaceutical companies in bringing to market new treatments and medications for diabetes.
Rocky Mountain Diabetes Center has 3 current physicians with extensive training and experience in overseeing subjects in clinical trials. Dr. John Liljenquist (emeritus) paved the way with these trials for over 30 years and has overseen hundreds of studies.
Drs. Carl Vance and Dave Liljenquist are continuing extensive research involvement having participated in clinical trials for over a decade. Dr. Joshua Smith is also contributing to clinical trial specifically targeting pediatric studies.
The research staff at Rocky Mountain Diabetes Center has over 130 years of combined of research experience.
Our staff is led by Mark Sulik who received his Pharm.D education from Idaho State University and is a Certified Clinical Research Professional.
The team also includes 7 certified research coordinators with an exceptional regulatory documents department that has developed unique methods of managing the ever-changing documents in such a way that many auditors have suggested it be taught to other clinical research sites.
Clinical Research Types
Because medical research is always changing, our menu of current clinical trials is also very fluid. We frequently have trials for both Type 1 and Type 2 diabetes as well as diabetic neuropathy, diabetic nephropathy (kidney disease), hypertension, high cholesterol, and obesity.
Our goal is to provide safe and effective clinical trials offering the newest investigational products and technologies while keeping our subjects engaged and providing the best care available.
Not only does our participation in clinical trials further the knowledge of disease and its treatment, but it offers our patients a chance to participate in these exciting trials as well. By participating in clinical trials, our patients are able to receive novel new treatments not yet available to the general public. They are also part of the momentum fueling the growing knowledge base regarding a variety of diseases including both type 1 and type 2 diabetes, which is leading to more effective treatment.